PS ratio:
58.32+2.67(+4.80%)Summary
- As of today (May 31, 2025), VRNA price to sales ratio is 58.32, with a rise of +2.67 (+4.80%) during the most recent trading session on May 30, 2025.
- VRNA PS ratio is now -98.62% below its all-time high of 4229.54.
Performance
VRNA PS ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
PS ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
VRNA PS ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | +4.8% | +4.8% | +4.8% | +180.4% |
| 1 m1 month | +12.7% | +12.7% | +12.7% | - |
| 3 m3 months | -58.5% | +16.6% | +16.4% | +180.4% |
| 6 m6 months | -89.9% | +104.9% | +112.1% | - |
| ytdytd | -35.6% | +74.8% | +80.5% | - |
| 1 y1 year | - | +607.3% | +642.6% | - |
| 5 y5 years | - | +1605.9% | +10000.0% | - |
VRNA PS ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | 58.32 | at high | 45.48 | +28.2% |
| 3 m | 3-month | 140.47 | -58.5% | 38.71 | +50.7% |
| 6 m | 6-month | 579.40 | -89.9% | 38.71 | +50.7% |
| 1 y | 1-year | 582.01 | -90.0% | 38.71 | +50.7% |
| 3 y | 3-year | 4229.54 | -98.6% | 38.71 | +50.7% |
| 5 y | 5-year | 4229.54 | -98.6% | 5.87 | +893.5% |
| alltime | all time | 4229.54 | -98.6% | 5.87 | +893.5% |
VRNA PS ratio History
| Date | Value |
|---|---|
| 2025 | 58.32(-35.6%) |
| Date | Value |
|---|---|
| 2024 | 90.57(-97.9%) |
| 2022 | 4229.54 |
FAQ
- What is Verona Pharma price to sales ratio?
- What is the all time high PS ratio for Verona Pharma?
- What is VRNA price to sales ratio year-to-date change?
What is Verona Pharma price to sales ratio?
The current PS ratio of VRNA is 58.32
What is the all time high PS ratio for Verona Pharma?
Verona Pharma all-time high price to sales ratio is 4229.54
What is VRNA price to sales ratio year-to-date change?
Verona Pharma price to sales ratio has changed by -32.25 (-35.61%) since the beginning of the year